Celldex Therapeutics, Inc. · NASDAQ:CLDX
BlackRock, Inc. reported a 8.30% stake in Celldex Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc. reported a 8.30% stake in Celldex Therapeutics, Inc., 5,480,670 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 8.30%
- Shares
- 5,480,670
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 8.30% | 5,480,670 |
Source
Related
- Celldex Therapeutics, Inc.
- BlackRock, Inc.
- Celldex Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · May 15, 2026
- Schedule 13G/A · Kynam Capital Management, LP · May 15, 2026